Invesco Ltd (NYSE: IVZ) Loses -22.05% From High. Why That Could Change?

Currently, there are 448.00M common shares owned by the public and among those 439.86M shares have been available to trade.

The company’s stock has a 5-day price change of -4.75% and -14.86% over the past three months. IVZ shares are trading -12.81% year to date (YTD), with the 12-month market performance down to -2.68% lower. It has a 12-month low price of $14.16 and touched a high of $19.55 over the same period. IVZ has an average intraday trading volume of 4.08 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.23%, -13.24%, and -10.18% respectively.

Institutional ownership of Invesco Ltd (NYSE: IVZ) shares accounts for 90.24% of the company’s 448.00M shares outstanding.

It has a market capitalization of $6.82B and a beta (3y monthly) value of 1.25. The stock’s trailing 12-month PE ratio is 12.88, while the earnings-per-share (ttm) stands at $1.18. The company has a PEG of 1.03 and the debt-to-equity ratio at 0.52. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.23% over the week and 3.13% over the month.

Earnings per share for the fiscal year are expected to increase by 9.12%, and 11.25% over the next financial year. EPS should grow at an annualized rate of 12.54% over the next five years, compared to -1.69% over the past 5-year period.

Looking at the support for the IVZ, a number of firms have released research notes about the stock. Wells Fargo stated their Underweight rating for the stock in a research note on September 12, 2024, with the firm’s price target at $16. Barclays coverage for the Invesco Ltd (IVZ) stock in a research note released on August 27, 2024 offered a Equal Weight rating with a price target of $18. TD Cowen was of a view on January 04, 2024 that the stock is Outperform, while Keefe Bruyette gave the stock Outperform rating on December 14, 2023, issuing a price target of $15.50- $20. BMO Capital Markets on their part issued Market Perform rating on July 10, 2023.

Most Popular

Related Posts